Position in NVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,772,032
-$92,587 QoQ
Shares Held
11,307
-7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#459
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $202,731,943 across 16 Drug Manufacturers - General names. NVS ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
348,943 | $88,621,053 | |
| 2 | LLY |
ELI LILLY & Co
|
27,892 | $33,454,503 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,656 | $28,739,795 | |
| 4 | AMGN |
Amgen Inc
|
47,244 | $17,107,996 | |
| 5 | ABBV |
AbbVie Inc.
|
51,835 | $13,043,758 | |
| 6 | AZN |
Astrazeneca PLC
|
32,878 | $6,234,325 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
106,605 | $6,142,579 | |
| 8 | PFE |
Pfizer Inc
|
185,530 | $4,467,561 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,772,032 | 11,307 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $1,864,619 | 12,207 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $1,864,002 | 13,520 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,862,941 | 14,527 | Shares | Defined | 2025-11-20 | |
| 2025-06-30 | $4,990,814 | 41,243 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $4,621,849 | 41,459 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $4,031,747 | 41,432 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $4,762,287 | 41,404 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $1,212,366 | 11,388 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,101,560 | 11,388 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $1,162,630 | 11,414 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,175,903 | 11,653 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,102,804 | 11,987 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,067,411 | 11,766 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $898,133 | 11,816 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,001,680 | 11,850 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,143,206 | 13,028 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,143,582 | 13,074 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,074,998 | 13,145 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,240,407 | 13,595 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,214,499 | 14,208 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,375,183 | 14,563 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,363,098 | 15,675 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,436,480 | 16,447 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,347,809 | 16,347 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||